203 related articles for article (PubMed ID: 18829384)
1. In vivo functional evaluation of central cholinergic circuits in vascular dementia.
Di Lazzaro V; Pilato F; Dileone M; Profice P; Marra C; Ranieri F; Quaranta D; Gainotti G; Tonali PA
Clin Neurophysiol; 2008 Nov; 119(11):2494-500. PubMed ID: 18829384
[TBL] [Abstract][Full Text] [Related]
2. Functional evaluation of cerebral cortex in dementia with Lewy bodies.
Di Lazzaro V; Pilato F; Dileone M; Saturno E; Profice P; Marra C; Daniele A; Ranieri F; Quaranta D; Gainotti G; Tonali PA
Neuroimage; 2007 Aug; 37(2):422-9. PubMed ID: 17570682
[TBL] [Abstract][Full Text] [Related]
3. A review of transcranial magnetic stimulation in the in vivo functional evaluation of central cholinergic circuits in dementia.
Nardone R; Golaszewski S; Ladurner G; Tezzon F; Trinka E
Dement Geriatr Cogn Disord; 2011; 32(1):18-25. PubMed ID: 21822020
[TBL] [Abstract][Full Text] [Related]
4. Motor cortex cholinergic dysfunction in CADASIL: a transcranial magnetic demonstration.
Manganelli F; Ragno M; Cacchiò G; Iodice V; Trojano L; Silvaggio F; Scarcella M; Grazioli M; Santoro L; Perretti A
Clin Neurophysiol; 2008 Feb; 119(2):351-5. PubMed ID: 18065265
[TBL] [Abstract][Full Text] [Related]
5. Reduced short latency afferent inhibition in patients with Down syndrome and Alzheimer-type dementia.
Nardone R; Marth R; Ausserer H; Bratti A; Tezzon F
Clin Neurophysiol; 2006 Oct; 117(10):2204-10. PubMed ID: 16931146
[TBL] [Abstract][Full Text] [Related]
6. Dissociated effects of diazepam and lorazepam on short-latency afferent inhibition.
Di Lazzaro V; Pilato F; Dileone M; Tonali PA; Ziemann U
J Physiol; 2005 Nov; 569(Pt 1):315-23. PubMed ID: 16141274
[TBL] [Abstract][Full Text] [Related]
7. Cholinergic dysfunction in subcortical ischaemic vascular dementia: a transcranial magnetic stimulation study.
Nardone R; Bergmann J; Tezzon F; Ladurner G; Golaszewski S
J Neural Transm (Vienna); 2008 May; 115(5):737-43. PubMed ID: 18188496
[TBL] [Abstract][Full Text] [Related]
8. In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias.
Di Lazzaro V; Pilato F; Dileone M; Saturno E; Oliviero A; Marra C; Daniele A; Ranieri F; Gainotti G; Tonali PA
Neurology; 2006 Apr; 66(7):1111-3. PubMed ID: 16606932
[TBL] [Abstract][Full Text] [Related]
9. Cholinergic circuitry functioning in patients with vascular cognitive impairment--no dementia.
Bella R; Cantone M; Lanza G; Ferri R; Vinciguerra L; Puglisi V; Pennisi M; Ricceri R; Di Lazzaro V; Pennisi G
Brain Stimul; 2016; 9(2):225-33. PubMed ID: 26515786
[TBL] [Abstract][Full Text] [Related]
10. Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans.
Di Lazzaro V; Oliviero A; Saturno E; Dileone M; Pilato F; Nardone R; Ranieri F; Musumeci G; Fiorilla T; Tonali P
J Physiol; 2005 Apr; 564(Pt 2):661-8. PubMed ID: 15718269
[TBL] [Abstract][Full Text] [Related]
11. Vascular compliance is reduced in vascular dementia and not in Alzheimer's disease.
Dhoat S; Ali K; Bulpitt CJ; Rajkumar C
Age Ageing; 2008 Nov; 37(6):653-9. PubMed ID: 18703522
[TBL] [Abstract][Full Text] [Related]
12. Short latency afferent inhibition and facilitation in patients with writer's cramp.
Kessler KR; Ruge D; Ilić TV; Ziemann U
Mov Disord; 2005 Feb; 20(2):238-42. PubMed ID: 15368612
[TBL] [Abstract][Full Text] [Related]
13. Short latency afferent inhibition in Parkinson's disease patients with dementia.
Celebi O; Temuçin CM; Elibol B; Saka E
Mov Disord; 2012 Jul; 27(8):1052-5. PubMed ID: 22605543
[TBL] [Abstract][Full Text] [Related]
14. Reduced short latency afferent inhibition in diffuse axonal injury patients with memory impairment.
Fujiki M; Hikawa T; Abe T; Ishii K; Kobayashi H
Neurosci Lett; 2006 Sep; 405(3):226-30. PubMed ID: 16901641
[TBL] [Abstract][Full Text] [Related]
15. Absence of cholinergic deficits in "pure" vascular dementia.
Perry E; Ziabreva I; Perry R; Aarsland D; Ballard C
Neurology; 2005 Jan; 64(1):132-3. PubMed ID: 15642917
[TBL] [Abstract][Full Text] [Related]
16. Ten-Point Clock Test: a correlation analysis with other neuropsychological tests in dementia.
Moretti R; Torre P; Antonello RM; Cazzato G; Bava A
Int J Geriatr Psychiatry; 2002 Apr; 17(4):347-53. PubMed ID: 11994889
[TBL] [Abstract][Full Text] [Related]
17. Performance on the Rey-Osterrieth Complex Figure Test in Alzheimer disease and vascular dementia.
Cherrier MM; Mendez MF; Dave M; Perryman KM
Neuropsychiatry Neuropsychol Behav Neurol; 1999 Apr; 12(2):95-101. PubMed ID: 10223256
[TBL] [Abstract][Full Text] [Related]
18. Central cholinergic dysfunction measured "in vivo" correlates with different behavioral disorders in Alzheimer's disease and dementia with Lewy body.
Marra C; Quaranta D; Profice P; Pilato F; Capone F; Iodice F; Di Lazzaro V; Gainotti G
Brain Stimul; 2012 Oct; 5(4):533-8. PubMed ID: 22019082
[TBL] [Abstract][Full Text] [Related]
19. Dopamine differently modulates central cholinergic circuits in patients with Alzheimer disease and CADASIL.
Nardone R; Höller Y; Thomschewski A; Kunz AB; Lochner P; Golaszewski S; Trinka E; Brigo F
J Neural Transm (Vienna); 2014 Oct; 121(10):1313-20. PubMed ID: 24677024
[TBL] [Abstract][Full Text] [Related]
20. Cortical afferent inhibition is reduced in patients with idiopathic REM sleep behavior disorder and cognitive impairment: a TMS study.
Nardone R; Bergmann J; Kunz A; Christova M; Brigo F; Tezzon F; Trinka E; Golaszewski S
Sleep Med; 2012 Aug; 13(7):919-25. PubMed ID: 22726269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
